Douglas J. Williamson

Chief Medical Officer, Avadel Pharmaceuticals.

Companies

Vistagen Therapeutics, Inc.Board member Jul 31, 2026 to now¹
Acadia PharmaceuticalsExecutive VP, Research & Dev Feb 13, 2023 to Feb 13, 2023²
Avadel PharmaceuticalsChief Medical Officer Feb 16, 2022 to Feb 16, 2022³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVistagen Therapeutics, Inc., Board member
2
SEC EDGARAcadia Pharmaceuticals, Executive VP, Research & Dev
3
SEC EDGARAvadel Pharmaceuticals, Chief Medical Officer